Frontlight ResearchEarly access
Trial site
Centre Hospitalier Universitaire de Toulouse - Hopital Rangueil
- 5running trials
- 3closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Amyloidosis2 trials
- Heart failure2 trials
- Obesity2 trials
- Chronic kidney disease1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- Liver cirrhosis1 trial
- Lupus (SLE)1 trial
- Rheumatoid arthritis1 trial
- Type 2 diabetes1 trial
- Ulcerative colitis1 trial
- Phase
- Phase 35 trials
- Phase 23 trials
- Status
- Active, not recruiting3 trials
- Completed2 trials
- Recruiting2 trials
- Terminated1 trial
- Lead sponsor
- Amgen3 trials
- Novo Nordisk A/S3 trials
- InDex Pharmaceuticals1 trial
- Madrigal Pharmaceuticals, Inc.1 trial
Running trials
Active, not recruiting
Recruiting
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Heart failure1 recruiting
- Lupus (SLE)1 recruiting
- Obesity1 recruiting
- Rheumatoid arthritis1 recruiting
Closed trials
Completed
Terminated
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026